MAB814

antibody from R&D Systems

Targeting: IFNB1 IFB, IFF, IFNB

Western blot (Recommended by provider)

Blocking/Neutralizing (Recommended by provider)

Antibody Data

Product number

MAB814

Provider

R&D Systems

Product name

Anti-Human IFN-beta Monoclonal Antibody (Clone 76703)

Antibody type

Monoclonal

Antigen

E. coli-derived recombinant human IFN-β, Met22-Asn187

Description

Protein A or G purified from ascites

Reactivity

Human

Host

Mouse

Antigen sequence

P01574


Isotype

IgG

Vial size

500 µg

References

Submitted references

PUM1 is a biphasic negative regulator of innate immunity genes by suppressing LGP2.

Liu Y, Qu L, Liu Y, Roizman B, Zhou GG
Proceedings of the National Academy of Sciences of the United States of America 2017 Aug 15;114(33):E6902-E6911

---

Constitutively Active MAVS Inhibits HIV-1 Replication via Type I Interferon Secretion and Induction of HIV-1 Restriction Factors.

Gupta S, Termini JM, Issac B, Guirado E, Stone GW
PloS one 2016;11(2):e0148929

---

Sialylation of Campylobacter jejuni endotoxin promotes dendritic cell-mediated B cell responses through CD14-dependent production of IFN-β and TNF-α.

Huizinga R, van Rijs W, Bajramovic JJ, Kuijf ML, Laman JD, Samsom JN, Jacobs BC
Journal of immunology (Baltimore, Md. : 1950) 2013 Dec 1;191(11):5636-45

---

An assessment of biological potency and molecular characteristics of different innovator and noninnovator interferon-beta products.

Meager A, Dolman C, Dilger P, Bird C, Giovannoni G, Schellekens H, Thorpe R, Wadhwa M
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2011 Apr;31(4):383-92